Patrick Vallance, President - R&D, GlaxoSmithKline said the company is looking forward to more collaborations and is looking at a number of options to move ahead with its expansion plans.
first published: Feb 9, 2017 10:10 pm
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty hold 26,000 as Q3 updates trickle in? | Opening Bell
Live: Nifty extends fall to the 3rd day, breaks below 26,100 | Closing Bell
Live: Can Nifty hold 26,200, break 2-day dull performance? | Opening Bell
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
